nad+ with retatrutide (GLP-3) – Y&P Labs Retatrutide - Research Peptide –

Recent prescribing patterns underscore this trend

Heres what the weight-loss conversation keeps missing.

While they are often discussed in the context of weight loss, their origins (and their impact) are rooted in deeper biological systems that regulate appetite, blood sugar, and energy balance

Health impact:Transforming treatment for obesity, diabetes, and heart disease

2026 is likely the year that two new oral weight loss drugs from Novo Nordisk and Eli Lilly will reach patients in the U.S.

In true GNC fashion, we led the industry by doing what weve always done best: helping consumers live well through education, innovation, and trusted wellness solutions